Progestin-containing Intrauterine System [EPC]

Progestin-containing Intrauterine System [EPC] was reported 205505 times

Drugs of the Progestin-containing Intrauterine System [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 INTRA-UTERINE CONTRACEPTIVE DEVICE EXPELLED 5573 0.9913
1 ECTOPIC PREGNANCY WITH INTRAUTERINE DEVICE 291 0.9636
2 IUCD COMPLICATION 2441 0.9388
3 MEDICAL DEVICE MONITORING ERROR 258 0.9247
4 IUD MIGRATION 793 0.9178
5 UNINTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 29 0.9062
6 UTERINE PERFORATION 7463 0.8807
7 CONTRAINDICATED DEVICE USED 284 0.8765
8 PREGNANCY AFTER POST COITAL CONTRACEPTION 1978 0.8748
9 GENITAL HAEMORRHAGE 11258 0.8744
10 UTERINE CERVIX STENOSIS 453 0.8499
11 POST PROCEDURAL DISCOMFORT 1728 0.8248
12 INTRA-UTERINE CONTRACEPTIVE DEVICE REMOVAL 211 0.7873
13 ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE 1275 0.7478
14 UTERINE RUPTURE 1019 0.7201
15 DEVICE EXPULSION 45823 0.7059
16 MEDICAL DEVICE PAIN 1504 0.7018
17 MEDICAL DEVICE DISCOMFORT 2120 0.6933
18 PREGNANCY WITH CONTRACEPTIVE DEVICE 5974 0.6662
19 UTERINE STENOSIS 25 0.6098
20 GYNAECOLOGICAL CHLAMYDIA INFECTION 31 0.5849
21 MENSTRUATION IRREGULAR 15046 0.5612
22 COITAL BLEEDING 859 0.5510
23 RUPTURED ECTOPIC PREGNANCY 422 0.5445
24 FALLOPIAN TUBE PERFORATION 49 0.5444
25 MENSTRUATION DELAYED 5782 0.5330
26 DEVICE IMPLANTATION ERROR 45 0.5294
27 MEDICAL DEVICE ENTRAPMENT 44 0.5238
28 UTERINE SPASM 953 0.5205
29 DEVICE MISUSE 681 0.5151
30 LOOP ELECTROSURGICAL EXCISION PROCEDURE 72 0.5070
31 INTERNAL INJURY 324 0.4969
32 UTERINE CERVICAL PAIN 94 0.4821
33 DEVICE DISLOCATION 20723 0.4761
34 UTERINE SCAR 109 0.4739
35 UTERINE FIBROSIS 28 0.4590
36 DEVICE COMPONENT ISSUE 65 0.4422
37 DYSPAREUNIA 1988 0.4326
38 UTERINE INJURY 73 0.4320
39 UTERINE CERVICAL LACERATION 39 0.4286
40 CERVIX INJURY 30 0.4286
41 HYPOMENORRHOEA 1173 0.4273
42 UTERINE ADHESIONS 55 0.4264
43 OFF LABEL USE OF DEVICE 574 0.4242
44 GENITAL DISCHARGE 101 0.4226
45 ACTINOMYCES TEST POSITIVE 54 0.4186
46 COLPOSCOPY 23 0.4107
47 PELVIC INFLAMMATORY DISEASE 610 0.4086
48 ABORTION OF ECTOPIC PREGNANCY 47 0.3917
49 EMBEDDED DEVICE 3855 0.3888
50 DYSMENORRHOEA 5073 0.3823
51 UTERINE PAIN 389 0.3788
52 PELVIC PAIN 6886 0.3786
53 PENILE PAIN 1147 0.3764
54 PROCEDURAL DIZZINESS 121 0.3746
55 ABDOMINAL PAIN LOWER 9377 0.3705
56 VAGINAL HAEMORRHAGE 15044 0.3463
57 VAGINITIS BACTERIAL 216 0.3412
58 UTERINE TENDERNESS 29 0.3372
59 ADNEXA UTERI PAIN 427 0.3336
60 HYDROMETRA 61 0.3315
61 POLYMENORRHAGIA 26 0.3291
62 PELVIC ADHESIONS 78 0.3264
63 BREAST TENDERNESS 2459 0.3262
64 CERVICAL DISCHARGE 30 0.3261
65 VAGINAL DISCHARGE 3289 0.3247
66 DEVICE INTOLERANCE 77 0.3235
67 RETAINED PRODUCTS OF CONCEPTION 66 0.3220
68 POST ABORTION HAEMORRHAGE 46 0.3217
69 INFERTILITY FEMALE 500 0.3213
70 HAEMORRHAGE IN PREGNANCY 451 0.3145
71 PROCEDURAL PAIN 8573 0.3087
72 OVULATION PAIN 64 0.3048
73 IDIOPATHIC INTRACRANIAL HYPERTENSION 686 0.3048
74 HABITUAL ABORTION 34 0.2982
75 ANTEPARTUM HAEMORRHAGE 122 0.2940
76 VAGINAL ODOUR 368 0.2923
77 TUBO-OVARIAN ABSCESS 71 0.2910
78 COMPLICATION OF DEVICE INSERTION 5774 0.2899
79 ENDOMETRIAL ATROPHY 41 0.2847
80 CERVIX INFLAMMATION 38 0.2794
81 SUPPRESSED LACTATION 207 0.2756
82 AMENORRHOEA 4828 0.2751
83 PSYCHOGENIC PAIN DISORDER 27 0.2621
84 UTERINE MALPOSITION 30 0.2542
85 ABNORMAL MENSTRUAL CLOTS 44 0.2514
86 CHLAMYDIA TEST POSITIVE 28 0.2478
87 SALPINGITIS 79 0.2476
88 EXPIRED DEVICE USED 813 0.2450
89 HUMAN CHORIONIC GONADOTROPIN DECREASED 27 0.2432
90 PREMENSTRUAL SYNDROME 328 0.2385
91 UTERINE INFECTION 126 0.2382
92 GENITAL PAIN 351 0.2373
93 PELVIC DISCOMFORT 217 0.2294
94 MENORRHAGIA 4440 0.2259
95 UTERINE INFLAMMATION 49 0.2258
96 PERITONEAL ADHESIONS 57 0.2244
97 PELVIC INFECTION 102 0.2198
98 POST PROCEDURAL HAEMORRHAGE 2544 0.2183
99 MENOMETRORRHAGIA 411 0.2153
100 PREGNANCY TEST POSITIVE 83 0.2112
101 SALPINGECTOMY 114 0.1986
102 DEVICE ALLERGY 48 0.1920
103 ENDOMETRITIS 127 0.1910
104 PROCEDURAL HAEMORRHAGE 733 0.1872
105 MEDICAL DEVICE COMPLICATION 1381 0.1866
106 ADNEXA UTERI CYST 30 0.1852
107 OVARIAN CYST 1845 0.1844
108 HAEMORRHAGIC OVARIAN CYST 105 0.1826
109 PREMENSTRUAL DYSPHORIC DISORDER 37 0.1823
110 BENIGN INTRACRANIAL HYPERTENSION 226 0.1799
111 PENIS INJURY 62 0.1722
112 CERVIX HAEMORRHAGE UTERINE 33 0.1719
113 UTERINE HAEMORRHAGE 721 0.1691
114 ECTOPIC PREGNANCY 518 0.1683
115 CERVICITIS 75 0.1682
116 OVARIAN CYST RUPTURED 212 0.1651
117 BREAST PAIN 1760 0.1649
118 PROGESTERONE DECREASED 51 0.1640
119 PROCEDURAL VOMITING 105 0.1615
120 CERVIX DISORDER 116 0.1611
121 CERVICAL POLYP 61 0.1609
122 HIRSUTISM 214 0.1609
123 POLYMENORRHOEA 557 0.1605
124 GENITAL INFECTION FEMALE 31 0.1598
125 SMEAR CERVIX ABNORMAL 227 0.1597
126 LOSS OF LIBIDO 1433 0.1592
127 PATIENT DISSATISFACTION WITH DEVICE 40 0.1587
128 PATIENT-DEVICE INCOMPATIBILITY 108 0.1581
129 PROCEDURAL NAUSEA 127 0.1578
130 PLACENTA ACCRETA 34 0.1567
131 UTERINE CONTRACTIONS ABNORMAL 42 0.1544
132 HYPERTRICHOSIS 285 0.1536
133 GONORRHOEA 41 0.1519
134 DEVICE USE ISSUE 2625 0.1499
135 CHLOASMA 69 0.1484
136 COMPLICATION OF DEVICE REMOVAL 2667 0.1474
137 BREAST DISCOMFORT 151 0.1463
138 BACTERIAL VAGINOSIS 227 0.1450
139 METRORRHAGIA 2470 0.1447
140 FALLOPIAN TUBE DISORDER 42 0.1424
141 MENSTRUAL DISORDER 1179 0.1422
142 CHLAMYDIAL INFECTION 107 0.1415
143 UTERINE ENLARGEMENT 112 0.1411
144 CERVICAL DYSPLASIA 306 0.1400
145 POSTPARTUM DEPRESSION 34 0.1333
146 ADENOMYOSIS 76 0.1286
147 CERVICAL CYST 30 0.1271
148 BLIGHTED OVUM 49 0.1247
149 PROCEDURAL ANXIETY 84 0.1237
150 CHEMICAL POISONING 46 0.1233
151 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 124 0.1231
152 NIPPLE PAIN 250 0.1227
153 VOMITING IN PREGNANCY 44 0.1212
154 RETAINED PLACENTA OR MEMBRANES 35 0.1155
155 DIFFUSE ALOPECIA 211 0.1136
156 HEAVY MENSTRUAL BLEEDING 1022 0.1135
157 ENDOMETRIAL THICKENING 62 0.1113
158 PELVIC HAEMORRHAGE 24 0.1096
159 PELVIC FLUID COLLECTION 77 0.1092
160 BREAST SWELLING 290 0.1078
161 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1244 0.1074
162 BACTERIAL VULVOVAGINITIS 31 0.1073
163 HEPATIC ADENOMA 55 0.1064
164 UTERINE CYST 60 0.1054
165 UTERINE LEIOMYOMA 765 0.1046
166 OVARIAN ENLARGEMENT 40 0.1042
167 INTERMENSTRUAL BLEEDING 573 0.1024
168 ENDOMETRIAL DISORDER 42 0.1017
169 DEVICE PLACEMENT ISSUE 364 0.1015
170 ADNEXAL TORSION 32 0.1009
171 MENSTRUAL CLOTS 24 0.1000
172 PRODUCT SHAPE ISSUE 94 0.0995
173 HORMONE RECEPTOR POSITIVE BREAST CANCER 27 0.0993
174 NIPPLE DISORDER 60 0.0965
175 FOCAL NODULAR HYPERPLASIA 50 0.0962
176 BREAST DISCHARGE 167 0.0952
177 SEXUALLY TRANSMITTED DISEASE 41 0.0943
178 BENIGN HYDATIDIFORM MOLE 31 0.0937
179 ADNEXA UTERI MASS 27 0.0934
180 ABNORMAL UTERINE BLEEDING 234 0.0911
181 INFERTILITY 137 0.0910
182 OLIGOMENORRHOEA 195 0.0893
183 ENDOMETRIAL HYPERPLASIA 72 0.0889
184 LACTATION DISORDER 43 0.0883
185 DEVICE BREAKAGE 3528 0.0868
186 VULVOVAGINAL PAIN 404 0.0838
187 HUMAN PAPILLOMA VIRUS TEST POSITIVE 34 0.0835
188 ENDOMETRIAL HYPERTROPHY 33 0.0829
189 UTERINE MASS 34 0.0825
190 DEVICE PHYSICAL PROPERTY ISSUE 632 0.0824
191 MEDICAL DEVICE SITE DISCOMFORT 66 0.0822
192 VULVOVAGINITIS 24 0.0816
193 HIGH RISK PREGNANCY 33 0.0815
194 COMPLICATION OF PREGNANCY 62 0.0815
195 MATERNAL EXPOSURE BEFORE PREGNANCY 556 0.0813
196 HAEMOPERITONEUM 65 0.0811
197 CERVIX CARCINOMA STAGE 0 23 0.0804
198 DEVICE DEPLOYMENT ISSUE 1026 0.0802
199 UTERINE POLYP 143 0.0796
200 HAEMORRHAGIC CYST 30 0.0775
201 VAGINAL INFECTION 361 0.0766
202 HORMONE LEVEL ABNORMAL 374 0.0766
203 GENITAL DISCOMFORT 42 0.0758
204 PROCEDURAL HEADACHE 31 0.0756
205 PAPILLOEDEMA 340 0.0752
206 BREAST CYST 133 0.0751
207 PERITONEAL HAEMORRHAGE 104 0.0749
208 PREMATURE MENOPAUSE 69 0.0747
209 DYSFUNCTIONAL UTERINE BLEEDING 90 0.0741
210 PROGESTERONE RECEPTOR ASSAY POSITIVE 69 0.0739
211 FIBROADENOMA OF BREAST 33 0.0733
212 BLADDER PERFORATION 28 0.0724
213 POLYCYSTIC OVARIES 112 0.0722
214 MEDICAL DEVICE SITE PAIN 40 0.0710
215 ABORTION MISSED 88 0.0693
216 SYNCOPE VASOVAGAL 57 0.0690
217 INTRA-ABDOMINAL HAEMORRHAGE 164 0.0688
218 VULVOVAGINAL DRYNESS 221 0.0683
219 DEVICE INEFFECTIVE 73 0.0682
220 UTERINE DILATION AND CURETTAGE 61 0.0675
221 BREAST ENLARGEMENT 216 0.0659
222 VULVOVAGINAL MYCOTIC INFECTION 258 0.0655
223 INJURY 4602 0.0654
224 ALLERGY TO METALS 39 0.0643
225 VULVOVAGINAL DISCOMFORT 281 0.0635
226 ENDOMETRIOSIS 302 0.0633
227 DEVICE DIFFICULT TO USE 4192 0.0633
228 INTENTIONAL DEVICE USE ISSUE 52 0.0608
229 ENDOMETRIAL ADENOCARCINOMA 38 0.0597
230 ACTINOMYCOSIS 57 0.0595
231 WITHDRAWAL BLEED 42 0.0576
232 CYST RUPTURE 38 0.0560
233 MENOPAUSAL SYMPTOMS 129 0.0554
234 MOOD SWINGS 1753 0.0549
235 BURNOUT SYNDROME 31 0.0545
236 PREGNANCY ON CONTRACEPTIVE 79 0.0541
237 VULVOVAGINAL PRURITUS 273 0.0538
238 ACNE CYSTIC 160 0.0531
239 OESTROGEN RECEPTOR ASSAY POSITIVE 57 0.0503
240 VAGINAL DISORDER 47 0.0490
241 UTERINE DISORDER 112 0.0480
242 PERINEAL PAIN 34 0.0476
243 SUPRAPUBIC PAIN 24 0.0472
244 POST PROCEDURAL DISCHARGE 31 0.0459
245 EXPOSURE DURING BREAST FEEDING 150 0.0452
246 MIGRAINE WITH AURA 121 0.0445
247 BLOOD OESTROGEN INCREASED 26 0.0441
248 OVARIAN DISORDER 41 0.0436
249 VULVOVAGINAL SWELLING 78 0.0427
250 BLOOD OESTROGEN DECREASED 29 0.0413
251 OVARIAN MASS 30 0.0408
252 PLACENTA PRAEVIA 32 0.0407
253 DEPRESSION SUICIDAL 138 0.0398
254 SENSATION OF PRESSURE 35 0.0396
255 VULVOVAGINAL CANDIDIASIS 53 0.0392
256 HEMIANAESTHESIA 31 0.0388
257 ENDOMETRIAL CANCER 85 0.0386
258 FIBROCYSTIC BREAST DISEASE 28 0.0379
259 INTRACRANIAL PRESSURE INCREASED 211 0.0378
260 ABDOMINAL PAIN 8636 0.0371
261 FEAR OF DISEASE 66 0.0371
262 PAPILLOMA VIRAL INFECTION 61 0.0369
263 DEVICE ISSUE 3254 0.0362
264 OOPHORECTOMY 32 0.0358
265 HAEMANGIOMA OF LIVER 36 0.0357
266 TWIN PREGNANCY 30 0.0357
267 SCAR 605 0.0353
268 PRODUCT ADHESION ISSUE 1229 0.0344
269 ABORTION SPONTANEOUS 1358 0.0339
270 ABNORMAL WITHDRAWAL BLEEDING 31 0.0337
271 MOOD ALTERED 912 0.0334
272 POSTMENOPAUSAL HAEMORRHAGE 87 0.0333
273 PENILE HAEMORRHAGE 26 0.0319
274 GASTROINTESTINAL INJURY 84 0.0312
275 INTRADUCTAL PROLIFERATIVE BREAST LESION 39 0.0312
276 SUBCLAVIAN VEIN THROMBOSIS 34 0.0299
277 ABDOMINAL SYMPTOM 24 0.0297
278 PELVIC ABSCESS 34 0.0296
279 INVASIVE DUCTAL BREAST CARCINOMA 78 0.0287
280 AFFECTIVE DISORDER 222 0.0282
281 ABDOMINAL DISTENSION 2940 0.0281
282 ACNE 2105 0.0277
283 LIBIDO DISORDER 35 0.0269
284 CYST 334 0.0269
285 WEIGHT LOSS POOR 135 0.0264
286 DEVICE FAILURE 402 0.0264
287 COMPLICATION ASSOCIATED WITH DEVICE 382 0.0263
288 PRESYNCOPE 638 0.0262
289 PREGNANCY ON ORAL CONTRACEPTIVE 68 0.0259
290 PLACENTAL DISORDER 24 0.0254
291 POSTPARTUM HAEMORRHAGE 34 0.0252
292 BREAST MASS 167 0.0248
293 BLOOD LOSS ANAEMIA 55 0.0243
294 EMOTIONAL DISTRESS 2940 0.0243
295 PROCEDURAL COMPLICATION 186 0.0242
296 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 30 0.0238
297 ABDOMINAL ADHESIONS 75 0.0237
298 SEBORRHOEA 87 0.0237
299 PRODUCT MONITORING ERROR 34 0.0235
300 FOOD CRAVING 122 0.0232
301 UTERINE PROLAPSE 25 0.0230
302 MIGRAINE 2178 0.0228
303 GALACTORRHOEA 146 0.0227
304 BENIGN BREAST NEOPLASM 23 0.0226
305 PREGNANCY 449 0.0224
306 GENITAL RASH 32 0.0224
307 ANHEDONIA 585 0.0222
308 ALOPECIA AREATA 39 0.0222
309 ABDOMINAL TENDERNESS 110 0.0221
310 MENOPAUSE 57 0.0221
311 DEPRESSION 4897 0.0215
312 PREMATURE SEPARATION OF PLACENTA 33 0.0214
313 MATERNAL EXPOSURE DURING BREAST FEEDING 84 0.0207
314 PANIC ATTACK 750 0.0206
315 FEAR 545 0.0202
316 INCORRECT DOSAGE ADMINISTERED 99 0.0202
317 DEPRESSED MOOD 1069 0.0202
318 DEVICE DEFECTIVE 345 0.0199
319 VULVOVAGINAL BURNING SENSATION 121 0.0198
320 BREAST CANCER FEMALE 525 0.0196
321 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 120 0.0194
322 ADHESION 29 0.0192
323 DEVICE MATERIAL ISSUE 40 0.0190
324 FORMICATION 132 0.0189
325 IRRITABILITY 1134 0.0188
326 PRODUCT PHYSICAL ISSUE 380 0.0188
327 PRODUCT CONTAMINATION 67 0.0188
328 VISUAL FIELD DEFECT 136 0.0188
329 CERVIX CARCINOMA 73 0.0187
330 PREMATURE RUPTURE OF MEMBRANES 45 0.0186
331 BREAST DISORDER 38 0.0186
332 INTENTIONAL DEVICE MISUSE 82 0.0186
333 BLADDER DISCOMFORT 23 0.0184
334 PREGNANCY WITH IMPLANT CONTRACEPTIVE 86 0.0183
335 PELVIC VENOUS THROMBOSIS 26 0.0181
336 NEGATIVE THOUGHTS 53 0.0181
337 IMPATIENCE 34 0.0181
338 ACUTE ABDOMEN 26 0.0177
339 DEVICE ADHESION ISSUE 270 0.0176
340 WEIGHT INCREASED 3913 0.0175
341 FUNGAL INFECTION 581 0.0174
342 MENINGIOMA 272 0.0174
343 CYSTITIS INTERSTITIAL 28 0.0174
344 HAIR GROWTH ABNORMAL 120 0.0173
345 ANXIETY 4931 0.0173
346 APPLICATION SITE RASH 237 0.0172
347 GENITAL HERPES 26 0.0170
348 BACK PAIN 3919 0.0169
349 DEVICE USE ERROR 580 0.0167
350 AUTOIMMUNE THYROIDITIS 63 0.0166
351 AFFECT LABILITY 154 0.0160
352 ABORTION 45 0.0154
353 ABDOMINAL RIGIDITY 41 0.0151
354 EMOTIONAL DISORDER 463 0.0150
355 TUNNEL VISION 28 0.0149
356 CEREBRAL VENOUS THROMBOSIS 27 0.0149
357 ABORTION INDUCED 139 0.0147
358 DISCOMFORT 899 0.0147
359 ANXIETY DISORDER 49 0.0147
360 SKIN ODOUR ABNORMAL 57 0.0145
361 PRURITUS GENITAL 34 0.0144
362 EXPIRED DRUG ADMINISTERED 71 0.0143
363 LIBIDO INCREASED 29 0.0143
364 FEAR OF DEATH 32 0.0142
365 SUSPECTED PRODUCT QUALITY ISSUE 26 0.0142
366 TEARFULNESS 61 0.0142
367 INTENTIONAL PRODUCT MISUSE 1213 0.0138
368 CRYING 497 0.0137
369 ALOPECIA 2665 0.0136
370 MOTION SICKNESS 26 0.0135
371 ABNORMAL WEIGHT GAIN 166 0.0134
372 DEPRESSIVE SYMPTOM 47 0.0133
373 PSYCHOLOGICAL TRAUMA 115 0.0133
374 VERTIGO 809 0.0133
375 HYSTERECTOMY 113 0.0130
376 PRE-EXISTING CONDITION IMPROVED 81 0.0130
377 PATIENT DISSATISFACTION WITH TREATMENT 25 0.0130
378 PREMATURE LABOUR 72 0.0127
379 HAEMORRHAGIC ANAEMIA 55 0.0125
380 HOT FLUSH 941 0.0125
381 PAIN 7590 0.0123
382 TINNITUS 567 0.0123
383 CAESAREAN SECTION 143 0.0123
384 MUSCLE SPASMS 2252 0.0123
385 FLANK PAIN 115 0.0123
386 NORMAL NEWBORN 65 0.0119
387 PANIC REACTION 86 0.0119
388 NIGHT SWEATS 374 0.0116
389 HUNGER 160 0.0115
390 TRICHORRHEXIS 32 0.0115
391 POLLAKIURIA 471 0.0113
392 EMBOLISM VENOUS 34 0.0112
393 SELF ESTEEM DECREASED 27 0.0111
394 BLADDER PAIN 35 0.0110
395 NAUSEA 8649 0.0109
396 PRODUCT SOLUBILITY ABNORMAL 55 0.0109
397 MAJOR DEPRESSION 79 0.0108
398 FOETAL DEATH 56 0.0108
399 DYSURIA 397 0.0108
400 PANIC DISORDER 41 0.0106
401 HEADACHE 6583 0.0105
402 URINE ODOUR ABNORMAL 60 0.0102
403 PRODUCT ADMINISTRATION INTERRUPTED 80 0.0102
404 MICTURITION URGENCY 116 0.0101
405 APPENDICECTOMY 36 0.0101
406 VOMITING 4730 0.0101
407 APPLICATION SITE IRRITATION 125 0.0100
408 NERVOUSNESS 518 0.0099
409 ANGER 332 0.0098
410 IMPAIRED WORK ABILITY 209 0.0098
411 ABDOMINAL PAIN UPPER 1997 0.0097
412 BLOOD URINE PRESENT 181 0.0095
413 HYPERACUSIS 35 0.0094
414 ABDOMINAL INFECTION 24 0.0094
415 THROMBOPHLEBITIS SUPERFICIAL 28 0.0092
416 FEELING OF BODY TEMPERATURE CHANGE 54 0.0092
417 ERYTHEMA NODOSUM 32 0.0091
418 APPENDICITIS 84 0.0090
419 APATHY 131 0.0090
420 HYPERVENTILATION 52 0.0090
421 SUICIDAL IDEATION 800 0.0087
422 OLIGOHYDRAMNIOS 29 0.0087
423 GESTATIONAL DIABETES 41 0.0086
424 DIZZINESS 4286 0.0086
425 DIPLOPIA 222 0.0085
426 OCULAR ICTERUS 37 0.0085
427 INCREASED APPETITE 161 0.0084
428 TENSION HEADACHE 36 0.0084
429 ANTINUCLEAR ANTIBODY POSITIVE 27 0.0083
430 EXTRASYSTOLES 58 0.0083
431 PAROSMIA 62 0.0082
432 HAEMORRHAGE 842 0.0080
433 BLINDNESS TRANSIENT 59 0.0080
434 DECREASED INTEREST 47 0.0080
435 FEELING OF DESPAIR 37 0.0079
436 POST-TRAUMATIC STRESS DISORDER 53 0.0079
437 PHOTOPHOBIA 148 0.0079
438 MULTIPLE USE OF SINGLE-USE PRODUCT 44 0.0078
439 FRUSTRATION 28 0.0078
440 UNINTENDED PREGNANCY 81 0.0077
441 ACTIVITIES OF DAILY LIVING IMPAIRED 153 0.0077
442 NECK PAIN 431 0.0077
443 ROSACEA 35 0.0075
444 MENTAL DISORDER 326 0.0075
445 BACTERIAL INFECTION 139 0.0074
446 ADVERSE EVENT 683 0.0074
447 GROIN PAIN 65 0.0074
448 SELF-INJURIOUS IDEATION 31 0.0074
449 PRE-ECLAMPSIA 35 0.0074
450 PALPITATIONS 859 0.0073
451 VISION BLURRED 992 0.0072
452 PHARYNGITIS STREPTOCOCCAL 78 0.0072
453 PIGMENTATION DISORDER 44 0.0071
454 SYNCOPE 712 0.0071
455 QUALITY OF LIFE DECREASED 95 0.0071
456 URINE ABNORMALITY 32 0.0070
457 PROCTALGIA 45 0.0070
458 DISTURBANCE IN ATTENTION 376 0.0070
459 VARICOSE VEIN 36 0.0070
460 MICTURITION DISORDER 24 0.0069
461 ABDOMINAL DISCOMFORT 1159 0.0069
462 SEXUAL DYSFUNCTION 81 0.0069
463 FATIGUE 5330 0.0068
464 HYPERPHAGIA 27 0.0068
465 BRAIN FOG 106 0.0068
466 GENERAL PHYSICAL HEALTH DETERIORATION 772 0.0067
467 AMNESIA 433 0.0066
468 MATERNAL EXPOSURE DURING PREGNANCY 592 0.0066
469 FEELING ABNORMAL 1562 0.0065
470 APPLICATION SITE PRURITUS 147 0.0065
471 STREPTOCOCCAL INFECTION 36 0.0065
472 DRUG EXPOSURE DURING PREGNANCY 220 0.0065
473 URINARY TRACT DISORDER 29 0.0064
474 BIPOLAR DISORDER 70 0.0064
475 TENSION 39 0.0064
476 INFECTION 924 0.0064
477 AUTOIMMUNE DISORDER 62 0.0064
478 VISUAL IMPAIRMENT 783 0.0063
479 SENSATION OF HEAVINESS 24 0.0062
480 SENSATION OF FOREIGN BODY 52 0.0062
481 ADVERSE REACTION 81 0.0061
482 PRODUCT PRESCRIBING ISSUE 133 0.0061
483 PURULENT DISCHARGE 26 0.0061
484 OCULAR DISCOMFORT 68 0.0061
485 SLEEP DISORDER 426 0.0060
486 BREAST CANCER 561 0.0060
487 PHOTOPSIA 38 0.0060
488 TENDONITIS 93 0.0060
489 APPLICATION SITE REACTION 42 0.0060
490 FOETAL GROWTH RESTRICTION 36 0.0059
491 UTERINE CANCER 47 0.0058
492 MUSCULOSKELETAL PAIN 304 0.0058
493 GASTROINTESTINAL MOTILITY DISORDER 31 0.0058
494 MEDICATION ERROR 321 0.0058
495 MUSCLE TIGHTNESS 93 0.0057
496 BLOOD PROLACTIN INCREASED 27 0.0057
497 VITREOUS FLOATERS 56 0.0057
498 FRUSTRATION TOLERANCE DECREASED 46 0.0057
499 URINARY TRACT INFECTION 971 0.0057
500 HEAD DISCOMFORT 100 0.0056
501 DRUG INEFFECTIVE 7444 0.0056
502 BLINDNESS 230 0.0056
503 IRON DEFICIENCY ANAEMIA 52 0.0056
504 PERSONALITY CHANGE 52 0.0056
505 APPETITE DISORDER 37 0.0056
506 DEFORMITY 52 0.0056
507 AGGRESSION 277 0.0055
508 PETIT MAL EPILEPSY 28 0.0055
509 HYPOAESTHESIA 820 0.0055
510 FEELING HOT 334 0.0054
511 HYPERHIDROSIS 699 0.0054
512 CYSTITIS 172 0.0054
513 LIVE BIRTH 45 0.0054
514 FLATULENCE 304 0.0054
515 DEVICE MALFUNCTION 375 0.0053
516 PSYCHIATRIC SYMPTOM 39 0.0053
517 SECRETION DISCHARGE 66 0.0053
518 EXPOSURE DURING PREGNANCY 327 0.0053
519 GASTROINTESTINAL SOUNDS ABNORMAL 26 0.0052
520 PRURITUS GENERALISED 113 0.0052
521 COLD SWEAT 92 0.0052
522 HERPES VIRUS INFECTION 30 0.0052
523 GRAND MAL CONVULSION 48 0.0052
524 THYROID DISORDER 80 0.0052
525 SOCIAL AVOIDANT BEHAVIOUR 30 0.0052
526 SCREAMING 33 0.0052
527 PARAESTHESIA 807 0.0051
528 TENDERNESS 53 0.0051
529 POST PROCEDURAL INFECTION 41 0.0050
530 EXERCISE TOLERANCE DECREASED 29 0.0050
531 PROTEIN URINE PRESENT 25 0.0050
532 RASH GENERALISED 129 0.0050
533 STILLBIRTH 24 0.0050
534 PYELONEPHRITIS 43 0.0050
535 FOOD ALLERGY 38 0.0049
536 INTERNAL HAEMORRHAGE 56 0.0049
537 APPLICATION SITE ERYTHEMA 128 0.0049
538 MIDDLE INSOMNIA 91 0.0049
539 RASH MACULAR 169 0.0048
540 NO ADVERSE EVENT 868 0.0048
541 CHOLECYSTITIS CHRONIC 32 0.0048
542 APHAGIA 23 0.0048
543 ECZEMA 249 0.0048
544 URTICARIA 795 0.0047
545 OVERWEIGHT 25 0.0046
546 HAIR DISORDER 38 0.0046
547 FLUID RETENTION 234 0.0046
548 EAR DISCOMFORT 47 0.0046
549 FACIAL PARALYSIS 39 0.0046
550 DERMATITIS CONTACT 52 0.0046
551 OVARIAN CANCER 42 0.0046
552 GASTROINTESTINAL PAIN 50 0.0045
553 FURUNCLE 36 0.0045
554 TACHYCARDIA 403 0.0045
555 SKIN DISORDER 150 0.0045
556 PREMATURE BABY 134 0.0044
557 EXPIRED PRODUCT ADMINISTERED 147 0.0044
558 SKIN HYPERPIGMENTATION 38 0.0044
559 PREMATURE DELIVERY 70 0.0044
560 HIDRADENITIS 40 0.0044
561 NEUROLOGICAL SYMPTOM 25 0.0044
562 ANORECTAL DISCOMFORT 23 0.0043
563 DEVICE RELATED INFECTION 66 0.0043
564 POLYP 28 0.0043
565 LIMB DISCOMFORT 132 0.0043
566 INSOMNIA 1131 0.0042
567 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 301 0.0042
568 VITAMIN D DEFICIENCY 41 0.0042
569 INITIAL INSOMNIA 43 0.0042
570 HAIR TEXTURE ABNORMAL 56 0.0042
571 KIDNEY INFECTION 82 0.0042
572 HYPERPROLACTINAEMIA 27 0.0042
573 SURGERY 243 0.0041
574 LOSS OF CONSCIOUSNESS 529 0.0041
575 VISUAL ACUITY REDUCED 137 0.0041
576 SENSORY LOSS 33 0.0041
577 EYE MOVEMENT DISORDER 28 0.0041
578 URINARY INCONTINENCE 121 0.0041
579 OPTIC NEURITIS 37 0.0041
580 BODY TEMPERATURE INCREASED 83 0.0041
581 BOWEL MOVEMENT IRREGULARITY 31 0.0040
582 POOR QUALITY SLEEP 87 0.0040
583 WEIGHT FLUCTUATION 42 0.0040
584 RESTLESSNESS 144 0.0039
585 FIBROMYALGIA 94 0.0039
586 NEURALGIA 94 0.0039
587 CHOLECYSTECTOMY 44 0.0038
588 DEEP VEIN THROMBOSIS 249 0.0038
589 IRRITABLE BOWEL SYNDROME 82 0.0038
590 CIRCULATORY COLLAPSE 65 0.0038
591 DERMATITIS ALLERGIC 48 0.0038
592 PALLOR 103 0.0038
593 MATERNAL DRUGS AFFECTING FOETUS 29 0.0038
594 RENAL PAIN 40 0.0038
595 FEELING COLD 105 0.0038
596 SCIATICA 60 0.0038
597 ARTHRALGIA 1563 0.0038
598 PULMONARY EMBOLISM 354 0.0037
599 BLOOD IRON DECREASED 44 0.0037
600 METASTASES TO LYMPH NODES 25 0.0037
601 UNEVALUABLE EVENT 280 0.0037
602 IMPAIRED DRIVING ABILITY 42 0.0037
603 PERITONITIS 76 0.0037
604 HYPERTHYROIDISM 53 0.0037
605 ONYCHOCLASIS 25 0.0036
606 EPILEPSY 111 0.0036
607 BLADDER DISORDER 36 0.0036
608 FEELING JITTERY 69 0.0036
609 APHTHOUS ULCER 28 0.0036
610 DERMATITIS 75 0.0036
611 MUSCLE TWITCHING 82 0.0036
612 OROPHARYNGEAL DISCOMFORT 32 0.0035
613 PARANOIA 61 0.0035
614 HYPERAESTHESIA 29 0.0035
615 THROAT TIGHTNESS 95 0.0035
616 MUSCULOSKELETAL CHEST PAIN 54 0.0035
617 CHOLELITHIASIS 114 0.0035
618 FOREIGN BODY IN REPRODUCTIVE TRACT 31 0.0035
619 CONVULSION 198 0.0035
620 HEREDITARY ANGIOEDEMA 37 0.0034
621 HYPOTHYROIDISM 109 0.0034
622 DIZZINESS POSTURAL 33 0.0034
623 ABASIA 84 0.0034
624 SKIN DISCOLOURATION 156 0.0034
625 THROMBOSIS 273 0.0034
626 VITAMIN D DECREASED 29 0.0034
627 POST PROCEDURAL COMPLICATION 65 0.0034
628 RETCHING 72 0.0034
629 MUSCULOSKELETAL DISCOMFORT 58 0.0034
630 THIRST 60 0.0034
631 LYMPHADENOPATHY 118 0.0033
632 CHROMATURIA 75 0.0033
633 FACE OEDEMA 56 0.0033
634 MULTIPLE ALLERGIES 26 0.0033
635 CHILLS 387 0.0033
636 DYSPEPSIA 324 0.0033
637 MYALGIA 558 0.0033
638 APHASIA 99 0.0033
639 INCREASED TENDENCY TO BRUISE 30 0.0033
640 SHOCK HAEMORRHAGIC 26 0.0032
641 SWELLING FACE 207 0.0032
642 PSYCHOTIC DISORDER 93 0.0031
643 CHEST PAIN 583 0.0031
644 LOW BIRTH WEIGHT BABY 25 0.0031
645 BEDRIDDEN 41 0.0031
646 PAIN IN EXTREMITY 918 0.0031
647 SENSORY DISTURBANCE 50 0.0031
648 RASH PAPULAR 69 0.0031
649 MASS 43 0.0031
650 PYREXIA 1061 0.0031
651 PHARYNGITIS 38 0.0031
652 ASTHENIA 1146 0.0030
653 HYPERSOMNIA 87 0.0030
654 INTESTINAL PERFORATION 34 0.0030
655 BURNING SENSATION 212 0.0030
656 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 141 0.0030
657 PRODUCT ADMINISTRATION ERROR 61 0.0030
658 THINKING ABNORMAL 56 0.0030
659 IMPAIRED QUALITY OF LIFE 43 0.0030
660 ATRIAL SEPTAL DEFECT 25 0.0030
661 INTENTIONAL PRODUCT USE ISSUE 261 0.0030
662 MALAISE 1304 0.0030
663 GALLBLADDER DISORDER 53 0.0030
664 CARPAL TUNNEL SYNDROME 41 0.0029
665 PRODUCT USE IN UNAPPROVED INDICATION 718 0.0029
666 RASH PRURITIC 157 0.0029
667 VENTRICULAR EXTRASYSTOLES 30 0.0029
668 DRY EYE 144 0.0029
669 NEPHROLITHIASIS 131 0.0029
670 COELIAC DISEASE 28 0.0029
671 THERAPEUTIC RESPONSE UNEXPECTED 127 0.0028
672 DERMATITIS ATOPIC 149 0.0028
673 HAEMORRHOIDS 55 0.0028
674 SWELLING 262 0.0028
675 ERUCTATION 54 0.0028
676 ECONOMIC PROBLEM 42 0.0028
677 DRY THROAT 28 0.0028
678 INFLAMMATION 142 0.0027
679 PRURITUS 1057 0.0027
680 CHEST DISCOMFORT 278 0.0027
681 TEMPERATURE INTOLERANCE 28 0.0027
682 GAMMA-GLUTAMYLTRANSFERASE INCREASED 60 0.0027
683 TREMOR 448 0.0027
684 TRANSIENT ISCHAEMIC ATTACK 91 0.0027
685 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 129 0.0027
686 SLEEP APNOEA SYNDROME 51 0.0027
687 PHARYNGEAL SWELLING 26 0.0027
688 IMMUNE SYSTEM DISORDER 35 0.0027
689 HEART RATE INCREASED 260 0.0026
690 PERIPHERAL COLDNESS 36 0.0026
691 PHOTOSENSITIVITY REACTION 43 0.0026
692 PHARYNGEAL OEDEMA 40 0.0026
693 OBESITY 41 0.0026
694 SINUSITIS 262 0.0026
695 ARRHYTHMIA 121 0.0026
696 BLINDNESS UNILATERAL 36 0.0025
697 SLUGGISHNESS 26 0.0025
698 GASTROENTERITIS VIRAL 46 0.0025
699 MEMORY IMPAIRMENT 349 0.0025
700 EATING DISORDER 54 0.0025
701 RESTLESS LEGS SYNDROME 46 0.0025
702 SEIZURE 292 0.0025
703 LIP SWELLING 84 0.0025
704 EAR PAIN 49 0.0025
705 BRAIN NEOPLASM 23 0.0025
706 THYROID CANCER 30 0.0025
707 TOOTHACHE 45 0.0025
708 RASH 1077 0.0025
709 DYSSTASIA 72 0.0025
710 PRODUCT USE ISSUE 460 0.0024
711 WEIGHT DECREASED 682 0.0024
712 EAR INFECTION 65 0.0024
713 OROPHARYNGEAL PAIN 226 0.0024
714 MUSCULOSKELETAL STIFFNESS 213 0.0024
715 ISCHAEMIC STROKE 43 0.0024
716 SPEECH DISORDER 126 0.0024
717 SEASONAL ALLERGY 34 0.0024
718 CONSTIPATION 522 0.0024
719 HYPOAESTHESIA ORAL 36 0.0024
720 RASH ERYTHEMATOUS 114 0.0024
721 GASTROOESOPHAGEAL REFLUX DISEASE 191 0.0024
722 EYE SWELLING 88 0.0024
723 PARAESTHESIA ORAL 34 0.0024
724 GENERALISED TONIC-CLONIC SEIZURE 39 0.0024
725 GASTROINTESTINAL DISORDER 211 0.0024
726 LETHARGY 135 0.0023
727 GENERALISED OEDEMA 29 0.0023
728 NERVE INJURY 26 0.0023
729 HYPERTENSIVE CRISIS 26 0.0023
730 OEDEMA PERIPHERAL 282 0.0023
731 INCORRECT DRUG ADMINISTRATION DURATION 65 0.0023
732 MANIA 38 0.0023
733 SPINAL PAIN 27 0.0023
734 ADVERSE DRUG REACTION 206 0.0023
735 PRODUCT QUALITY ISSUE 311 0.0023
736 IMMUNODEFICIENCY 34 0.0023
737 HYPERTENSION 482 0.0023
738 PAIN OF SKIN 61 0.0023
739 DECREASED APPETITE 525 0.0023
740 CANDIDA INFECTION 38 0.0022
741 ABNORMAL BEHAVIOUR 89 0.0022
742 HEMIPARESIS 38 0.0022
743 SKIN INFECTION 25 0.0022
744 MENTAL IMPAIRMENT 54 0.0022
745 SUICIDE ATTEMPT 135 0.0022
746 DECREASED ACTIVITY 24 0.0022
747 APPLICATION SITE PAIN 49 0.0022
748 PAIN IN JAW 63 0.0022
749 CONTRAINDICATED PRODUCT ADMINISTERED 67 0.0022
750 HEART RATE IRREGULAR 50 0.0022
751 ORAL HERPES 43 0.0022
752 PHARMACEUTICAL PRODUCT COMPLAINT 57 0.0022
753 ABSCESS 35 0.0022
754 GASTRIC DISORDER 75 0.0022
755 CARDIOVASCULAR DISORDER 55 0.0022
756 DIARRHOEA 1397 0.0022
757 BREAST CANCER METASTATIC 23 0.0021
758 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 433 0.0021
759 HYPERSENSITIVITY 396 0.0021
760 EYE PAIN 120 0.0021
761 LOCAL SWELLING 37 0.0021
762 INTRAOCULAR PRESSURE INCREASED 27 0.0021
763 WHITE BLOOD CELL COUNT INCREASED 81 0.0021
764 FREQUENT BOWEL MOVEMENTS 57 0.0021
765 BLOOD PRESSURE INCREASED 321 0.0021
766 COGNITIVE DISORDER 98 0.0021
767 OEDEMA 113 0.0021
768 INFLUENZA LIKE ILLNESS 171 0.0021
769 OFF LABEL USE 1819 0.0021
770 ROAD TRAFFIC ACCIDENT 86 0.0021
771 NASAL CONGESTION 120 0.0020
772 SKIN BURNING SENSATION 146 0.0020
773 ANOREXIA 26 0.0020
774 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 110 0.0020
775 INCORRECT PRODUCT ADMINISTRATION DURATION 43 0.0020
776 COAGULOPATHY 33 0.0020
777 GINGIVAL BLEEDING 27 0.0020
778 ANKYLOSING SPONDYLITIS 26 0.0020
779 FEEDING DISORDER 40 0.0020
780 INTERVERTEBRAL DISC PROTRUSION 43 0.0020
781 SYSTEMIC LUPUS ERYTHEMATOSUS 69 0.0019
782 SOMNOLENCE 391 0.0019
783 BLOOD PRESSURE DECREASED 129 0.0019
784 NIGHTMARE 67 0.0019
785 TOOTH DISORDER 43 0.0019
786 VIRAL INFECTION 64 0.0019
787 SWOLLEN TONGUE 60 0.0019
788 ANGIOEDEMA 84 0.0019
789 TOOTH INFECTION 25 0.0019
790 ASCITES 55 0.0019
791 ANOSMIA 27 0.0019
792 INFUSION SITE PAIN 24 0.0019
793 BLOOD BILIRUBIN INCREASED 50 0.0018
794 THROAT IRRITATION 83 0.0018
795 DYSARTHRIA 69 0.0018
796 DYSGEUSIA 136 0.0018
797 BLOOD POTASSIUM DECREASED 55 0.0018
798 LIVER FUNCTION TEST ABNORMAL 53 0.0018
799 INJURY ASSOCIATED WITH DEVICE 37 0.0018
800 STAPHYLOCOCCAL INFECTION 59 0.0018
801 BACK DISORDER 29 0.0018
802 JOINT SWELLING 215 0.0018
803 BALANCE DISORDER 153 0.0018
804 FOETAL EXPOSURE DURING PREGNANCY 143 0.0018
805 INTENTIONAL DOSE OMISSION 50 0.0018
806 JOINT STIFFNESS 46 0.0018
807 ANAPHYLACTIC REACTION 95 0.0017
808 GASTROENTERITIS 25 0.0017
809 UPPER RESPIRATORY TRACT INFECTION 79 0.0017
810 LYMPHOCYTE COUNT DECREASED 30 0.0017
811 PERIPHERAL SWELLING 261 0.0017
812 WITHDRAWAL SYNDROME 71 0.0017
813 PANCREATITIS ACUTE 38 0.0017
814 SKIN IRRITATION 77 0.0017
815 CONTUSION 161 0.0017
816 DISABILITY 33 0.0017
817 PRODUCT DOSE OMISSION IN ERROR 47 0.0017
818 ANAEMIA 316 0.0017
819 DISORIENTATION 65 0.0016
820 JOINT INJURY 35 0.0016
821 EYE PRURITUS 55 0.0016
822 HAEMATURIA 56 0.0016
823 JAUNDICE 44 0.0016
824 INSURANCE ISSUE 25 0.0016
825 MOBILITY DECREASED 117 0.0016
826 BLOOD PRESSURE FLUCTUATION 39 0.0016
827 SINUS DISORDER 32 0.0016
828 HEPATIC STEATOSIS 30 0.0016
829 COLON CANCER 24 0.0016
830 MULTIPLE SCLEROSIS 77 0.0016
831 NERVOUS SYSTEM DISORDER 50 0.0016
832 MUSCULAR WEAKNESS 182 0.0016
833 GASTRITIS 42 0.0016
834 LIVER FUNCTION TEST INCREASED 34 0.0016
835 GAIT DISTURBANCE 303 0.0016
836 HAEMATEMESIS 40 0.0016
837 FLUSHING 160 0.0016
838 DRY SKIN 210 0.0016
839 C-REACTIVE PROTEIN INCREASED 57 0.0016
840 HAEMATOCRIT DECREASED 31 0.0016
841 CEREBRAL INFARCTION 38 0.0016
842 DEAFNESS 40 0.0015
843 SHOCK 35 0.0015
844 BRONCHITIS 112 0.0015
845 PRODUCT AVAILABILITY ISSUE 34 0.0015
846 DRY MOUTH 121 0.0015
847 HAEMATOCHEZIA 82 0.0015
848 MUSCULOSKELETAL DISORDER 28 0.0015
849 BLISTER 81 0.0014
850 DRUG INTERACTION 228 0.0014
851 ANAPHYLACTIC SHOCK 37 0.0014
852 BONE PAIN 84 0.0014
853 ALANINE AMINOTRANSFERASE INCREASED 88 0.0014
854 SNEEZING 32 0.0014
855 SEPTIC SHOCK 62 0.0014
856 NASOPHARYNGITIS 262 0.0014
857 ERYTHEMA 289 0.0014
858 DYSPNOEA 791 0.0014
859 CONDITION AGGRAVATED 423 0.0014
860 URINARY RETENTION 46 0.0014
861 ILLNESS 142 0.0014
862 ABNORMAL DREAMS 38 0.0014
863 INFLUENZA 153 0.0014
864 AGEUSIA 34 0.0014
865 HAEMATOMA 35 0.0013
866 RECTAL HAEMORRHAGE 58 0.0013
867 PULMONARY HYPERTENSION 28 0.0013
868 INTENTIONAL SELF-INJURY 27 0.0013
869 SEPSIS 148 0.0013
870 ANGINA PECTORIS 38 0.0013
871 AGITATION 97 0.0013
872 GASTRIC ULCER 25 0.0013
873 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 237 0.0013
874 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 24 0.0013
875 MOVEMENT DISORDER 42 0.0013
876 RESPIRATORY TRACT INFECTION 34 0.0013
877 PRODUCT PRESCRIBING ERROR 31 0.0013
878 RHINORRHOEA 83 0.0013
879 ASTHMA 145 0.0013
880 SKIN LESION 35 0.0013
881 PRODUCT COMPLAINT 32 0.0013
882 PSORIATIC ARTHROPATHY 51 0.0013
883 HAEMOPTYSIS 35 0.0013
884 EYE DISORDER 41 0.0012
885 RESPIRATORY DISORDER 37 0.0012
886 SKIN FISSURES 24 0.0012
887 HEART RATE DECREASED 43 0.0012
888 HAEMOGLOBIN DECREASED 125 0.0012
889 DYSKINESIA 49 0.0012
890 ASPARTATE AMINOTRANSFERASE INCREASED 64 0.0012
891 DISEASE RECURRENCE 57 0.0012
892 SKIN EXFOLIATION 101 0.0012
893 GAIT INABILITY 40 0.0012
894 CONFUSIONAL STATE 189 0.0012
895 HEAD INJURY 37 0.0012
896 CEREBROVASCULAR ACCIDENT 198 0.0012
897 BLOOD ALKALINE PHOSPHATASE INCREASED 29 0.0012
898 COLITIS ULCERATIVE 52 0.0012
899 BLOOD PRESSURE ABNORMAL 23 0.0012
900 PSORIASIS 151 0.0012
901 EPISTAXIS 86 0.0011
902 COUGH 322 0.0011
903 HEPATIC ENZYME INCREASED 77 0.0011
904 LACRIMATION INCREASED 34 0.0011
905 RASH MACULO-PAPULAR 25 0.0011
906 HYPOTENSION 225 0.0011
907 OCULAR HYPERAEMIA 53 0.0011
908 DYSPHAGIA 104 0.0011
909 DYSPNOEA EXERTIONAL 41 0.0011
910 BLOOD CHOLESTEROL INCREASED 50 0.0011
911 RHEUMATOID ARTHRITIS 119 0.0010
912 COVID-19 183 0.0010
913 EYE IRRITATION 60 0.0010
914 LIVER DISORDER 46 0.0010
915 DEHYDRATION 137 0.0010
916 ARTHROPATHY 57 0.0010
917 PANCREATITIS 54 0.0010
918 DRUG-INDUCED LIVER INJURY 32 0.0010
919 EXTRA DOSE ADMINISTERED 41 0.0010
920 MENTAL STATUS CHANGES 28 0.0010
921 ARTHRITIS 79 0.0010
922 DYSPHONIA 58 0.0010
923 HEPATITIS 25 0.0010
924 PRODUCT SUBSTITUTION ISSUE 56 0.0010
925 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 28 0.0010
926 HYPOPHAGIA 24 0.0009
927 ACUTE MYOCARDIAL INFARCTION 26 0.0009
928 PRODUCT DOSE OMISSION ISSUE 259 0.0009
929 DRUG ADMINISTRATION ERROR 27 0.0009
930 CELLULITIS 44 0.0009
931 TYPE 2 DIABETES MELLITUS 29 0.0009
932 DEPRESSED LEVEL OF CONSCIOUSNESS 34 0.0009
933 INJECTION SITE RASH 26 0.0008
934 MULTIPLE SCLEROSIS RELAPSE 58 0.0008
935 COLITIS 30 0.0008
936 TREATMENT NONCOMPLIANCE 43 0.0008
937 THERAPEUTIC RESPONSE SHORTENED 26 0.0008
938 DRUG DOSE OMISSION 126 0.0008
939 THERAPY CESSATION 39 0.0008
940 INJECTION SITE PRURITUS 50 0.0007
941 HALLUCINATION 56 0.0007
942 THERAPEUTIC PRODUCT EFFECT DECREASED 33 0.0007
943 HERPES ZOSTER 42 0.0007
944 INJECTION SITE SWELLING 56 0.0007
945 INJECTION SITE REACTION 50 0.0007
946 BRADYCARDIA 38 0.0007
947 HYPOACUSIS 30 0.0007
948 FALL 229 0.0007
949 RENAL DISORDER 32 0.0007
950 HYPOGLYCAEMIA 33 0.0007
951 NEOPLASM MALIGNANT 45 0.0007
952 THERAPY NON-RESPONDER 30 0.0007
953 PRODUCTIVE COUGH 31 0.0006
954 INFUSION RELATED REACTION 43 0.0006
955 OSTEOARTHRITIS 27 0.0006
956 CARDIAC DISORDER 58 0.0006
957 INJECTION SITE ERYTHEMA 75 0.0006
958 BLOOD GLUCOSE DECREASED 29 0.0006
959 DRUG INTOLERANCE 54 0.0006
960 PRODUCT STORAGE ERROR 48 0.0005
961 INCORRECT DOSE ADMINISTERED 124 0.0005
962 THERAPEUTIC RESPONSE DECREASED 32 0.0005
963 HOSPITALISATION 80 0.0005
964 INJECTION SITE BRUISING 40 0.0005
965 DIABETES MELLITUS 37 0.0005
966 NEUROPATHY PERIPHERAL 46 0.0005
967 PLATELET COUNT DECREASED 50 0.0005
968 INTENTIONAL OVERDOSE 30 0.0005
969 MYOCARDIAL INFARCTION 80 0.0005
970 ILL-DEFINED DISORDER 27 0.0004
971 THERAPY INTERRUPTED 31 0.0004
972 UNDERDOSE 31 0.0004
973 PRODUCT DOSE OMISSION 27 0.0004
974 PNEUMONIA 132 0.0004
975 DRUG WITHDRAWAL SYNDROME 35 0.0004
976 TREATMENT FAILURE 33 0.0004
977 WHITE BLOOD CELL COUNT DECREASED 43 0.0004
978 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 28 0.0004
979 RESPIRATORY FAILURE 28 0.0004
980 INJECTION SITE PAIN 113 0.0004
981 BLOOD GLUCOSE INCREASED 67 0.0004
982 THROMBOCYTOPENIA 37 0.0003
983 CARDIAC ARREST 27 0.0003
984 DISEASE PROGRESSION 36 0.0003
985 ATRIAL FIBRILLATION 28 0.0003
986 ACCIDENTAL EXPOSURE TO PRODUCT 29 0.0003
987 ACUTE KIDNEY INJURY 34 0.0002
988 NEUTROPENIA 26 0.0002
989 OVERDOSE 38 0.0002
990 TOXICITY TO VARIOUS AGENTS 24 0.0001
991 DEATH 55 0.0001